Fosun Pharma says BioNTech to supply 100 mln doses of COVID-19 vaccine to China

Shanghai Fosun Pharmaceutical Group said on Wednesday that BioNTech SE agreed to supply 100 million doses of its COVID-19 vaccine, if approved, to mainland China next year.

Pfizer and BioNTech's COVID-19 vaccine has already received approval for emergency use in several countries, including the U.S., UK, and Singapore.